Close
CDMO Safety Testing 2026
Novotech

HKSTP and Hospital Authority Establish Data Collaboration Lab at Science Park to Enable Industry Access to Clinical Big Data

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.
- Advertisement -

Hong Kong Science and Technology Parks Corporation (HKSTP) and Hospital Authority signed an agreement to co-launch the HKSTP HA Data Collaboration Lab at Hong Kong Science Park in October 2023, providing 1,400+ Park companies and their partners with direct access to anonymous clinical data from HAโ€™s database of around 200,000 patients. The HKSTP HA Data Collaboration Lab will be the first and only access portal to HAโ€™s database for nonacademic research and development (R&D) purposes, allowing the industry to transform clinical data into life-changing biomedical and healthcare innovations.

Mr Albert Wong, CEO of HKSTP, said: โ€œHKSTP HA Data Collaboration Lab is a game-changing addition to HKSTPโ€™s innovation and technology (I&T) ecosystem. Seamless data collaboration among hospitals, academia and the industry will fuel Hong Kongโ€™s healthcare transformation and digital economy ambitions. With the support of the new HKSTP HA Data Collaboration Lab, we look forward to witnessing the birth of more breakthrough technologies by our Park companies as they seek to positively impact lives across the globe.โ€

Dr Tony Ko, Chief Executive of Hospital Authority, said: โ€œOur partnership with HKSTP is another major step in our collective goal with the government to provide wider industry access to clinical data and drive collaboration and innovation. This is a big moment in our mission to accelerate healthcare transformation and elevate Hong Kongโ€™s healthcare capacity and quality at all levels.โ€

Located on 2/F, Building 19W of Hong Kong Science Park, HKSTP HA Data Collaboration Lab will provide comprehensive infrastructure to enable exclusive access to HAโ€™s Self-service Data Platform, which consists of clinical records from around 200,000 patients randomly selected from 2007 and 2017, stratified by age and gender, to support the development of new innovations. Data ranges from patientsโ€™ demographic characteristics, attendance records to hospitals and clinics, clinical diagnoses, procedures, medication records, to laboratory and radiology examination results.

HKSTP has embedded a series of stringent security measures to protect data security and privacy. Physical measures include onsite personnel, surveillance systems, and a dedicated room for exclusive access. In addition, the network is isolated from the Internet to prevent unauthorised access, while data cannot be downloaded, saved, or printed by users, and all personal information is removed from the database to protect patient anonymity. HKSTP has also established two governance committees the HKSTP Clinical Research Ethics Committee and the Data Governance Committee to ensure compliance with all matters related to data protection and privacy, as well as clinical research ethics.

The HKSTP HA Data Collaboration Lab will officially launch in October 2023 after a pilot run. By then, all 1,400+ HKSTP Park companies primarily biotech and healthcare companies their partners and academic researchers, can apply for access. Each application will allow for five-day access for
exploration.

This collaboration stems from Hong Kongโ€™s 2021 Policy Address, which tasked HKSTP and HA to promote better collaboration and data sharing among the R&D and healthcare sectors. Access to the Self-service Data Platform was exclusive for academic research and publications at a few secure locations. The establishment of HKSTP HA Data Collaboration Lab at Hong Kong Science Park will expand the user base from academia to the industry, marking another milestone in HKSTPโ€™s journey of strengthening collaboration with stakeholders from government, industry, academic and research sectors to transform Hong Kong into an international I&T hub.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.

Digital Supply Networks Strengthening Pharma Delivery

The transition from traditional linear supply chains to integrated digital supply networks is revolutionizing how pharmaceutical products are delivered. By leveraging connected visibility and real-time analytics, these networks enhance the resilience of cold chain operations. This technological evolution ensures that healthcare systems can respond dynamically to shifts in demand while maintaining the highest standards of safety and efficiency for patient care.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป